UBS ASSET MANAGEMENT AMERICAS LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$95,665,000
-89.8%
13,455
-87.8%
0.00%
-100.0%
Q4 2018$940,775,000
-81.8%
110,161
-57.4%
0.00%
-75.0%
Q3 2018$5,171,025,000
-3.7%
258,293
+24.2%
0.00%0.0%
Q2 2018$5,371,968,000
+19.9%
207,974
+10.9%
0.00%0.0%
Q1 2018$4,480,748,000
-32.9%
187,479
-4.9%
0.00%
-33.3%
Q4 2017$6,679,651,000
+2578915.8%
197,098
+1051.9%
0.01%
Q2 2016$259,000
-38.8%
17,110
-41.6%
0.00%
Q1 2016$423,000
-7.6%
29,281
+81.1%
0.00%
-100.0%
Q4 2015$458,000
+31.2%
16,166
-22.4%
0.00%
Q3 2015$349,000
-40.5%
20,840
-6.9%
0.00%
-100.0%
Q2 2015$587,00022,3730.00%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders